Should I buy Thermo Fisher Scientific (TMO) stock or is it too late?
⭐ The most reliable of them, either direction: Barclays — 60% of its targets hit on this sector (645 calls tested). It aims for $750 (+13 %), call made on October 8, 2026, maturing on October 8, 2027 (6 d ago).
Firm-by-firm track record on Thermo Fisher Scientific
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| UBS | 91 % | +29.7 % | 11 | $590 -11% |
| Citigroup | 71 % | +20.7 % | 17 | $685 +3% |
| Argus Research | 86 % | +18.8 % | 7 | $610 -8% |
| BTIG | 67 % | +14.0 % | 9 | $718 +8% |
| Stifel | 73 % | +13.7 % | 15 | $600 -10% |
| Morgan Stanley | 76 % | +13.6 % | 25 | $730 +10% |
| Baird | 70 % | +12.8 % | 30 | $639 -4% |
| Barclays | 62 % | +11.0 % | 26 | $750 +13% |
✅ Reasons to believe
- 73% of analysts rate it a buy (Buy consensus, 11 ratings) — a sign of market conviction.
⚠️ Reasons to hesitate
- Even the most reliable firm on TMO, UBS (91% hit rate, 11 scored calls), only targets $590 (call made on October 23, 2025, maturing on October 23, 2026) (-11%) in its most recent call. The stock may already have run past its target.
- The consensus is not unanimous: of 11 ratings, 3 are neutral.
- Limited upside: the median target is only -10% from the current price.
- High valuation (P/E ~36): strong growth is already "priced in", leaving little room for error.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Negligible dividend (0.3% yield): your return depends mostly on price appreciation.
The analyst consensus on TMO
Median target $600 (-10%) · 11 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Thermo Fisher Scientific now?
We won't decide for you. The facts: 73% of analysts rate it a buy, median target $600 (-10%), and UBS (most reliable on TMO, 91%) targets $590. Weigh that against valuation (P/E ~36). This is not personalized advice.
Is it too late to invest in Thermo Fisher Scientific?
The stated upside is small: the median target ($600) sits just -10% from the price ($663) (most reliable on TMO: UBS, 91%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Thermo Fisher Scientific still worth investing in?
It depends on the gap between the price ($663) and its estimated value: analysts target $600 on median (-10%), with 73% buys (most reliable on TMO: UBS, 91%). Cross-check with their real reliability on TMO and the cautions above. Information, not advice.
What's the main risk in buying TMO?
Even the most reliable firm on TMO, UBS (91% hit rate, 11 scored calls), only targets $590 (call made on October 23, 2025, maturing on October 23, 2026) (-11%) in its most recent call. The stock may already have run past its target.
→ Go deeper: the full Thermo Fisher Scientific profile (consensus, analyst reliability, price target, performance).